It seems very unlikely that the glucagon released by GIPR activation counteracts the incretin effect, as this would result in a counterproductive postprandial response that would not promote metabolic homeostasis in the individual
But there are times when a doctor will deliberately lower a patients dose to taper off or fine-tune resultswith proper supervision. Thats worlds away from self-directed dose-skipping because you saw a hack on social media
Semaglutide users need a more structured approach
HSA/FSA Considerations Pre-Tax Savings: Using HSA/FSA Funds: Compounded tirzepatide is HSA/FSA eligible Consultations are eligible Supplies are eligible Effectively 20-30% discount (depending on tax bracket) Cost After Tax Savings: $349/month at 25% tax bracket: Effective cost: ~$262/month Annual savings: $1,044 $349/month at 30% tax bracket: Effective cost: ~$244/month Annual savings: $1,257 Makes already affordable treatment even more accessible
for example, owing to adverse effects, patient preference, cost pressures or formulary decisions
Compounding pharmacies have begun selling unregulated versions of semaglutide